(ノ^_^)ノ try 1ClickRepeater.com repeat youtube videos

FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More

Free Button: Daily News
Free Button: Daily News

  Info

Description

George R. Simon, MD, reports on an FDA approval in bladder cancer, a breakthrough therapy designation in diffuse large B-cell lymphoma, an ODAC hearing scheduled for a drug in HER2-positive breast cancer, an FDA elimination for REMS certification prior to select treatments, and 2 disappointing phase III results in non–small cell lung cancer and triple-negative breast cancer.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
👕 Try MeTee.com: publish meme shirts in seconds and earn a commission forever

Related

  FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and Breakthrough Designation in NSCLC   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More   FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More   FDA Approvals in ALL and Breast Cancer, Priority Reviews in CML and Follicular Lymphoma, and More   Breakthrough Designation in ALL, HIFU FDA Approval, Breast Cancer Screening Update, and More   FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More   FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year   FDA Approval in AML, NDA Submitted in Myeloma, Clinical Hold on CAR T-cell Therapy Trials, and More   21st Century Cures Act Passes and 2016 Highlights from SABCS and WCLC   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   The FDA Approval of Atezolizumab in Bladder Cancer   FDA Approval of Durvalumab for Bladder Cancer   Durvalumab FDA Approval for Bladder Cancer   FDA approves breakthrough CAR-T therapy for leukemia   FDA Approval in AML, Priority Review Designation in NSCLC, and More   FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   John McCamant on Anti-Cancer Therapies   Niraparib Maintenance for Recurrent Ovarian Cancer   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More   Dr. Garcia on FDA Approval of Pembrolizumab in Bladder Cancer   FDA Approvals, Breakthrough Designations, Priority Reviews, and More   Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More   FDA Approves Treatment for Childhood Leukemia   FDA Approval in Lung Cancer, Priority Reviews in HCC and NHL, and an ODAC Recommendation   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More   Psychedelic drug being looked at to treat PTSD   Breakthrough Therapy Designation in CSCC, 2017 ESMO Congress Highlights, and More   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   Dr. Kelly on the FDA Approval of Ribociclib in HR+ Breast Cancer   FDA Approvals in Breast Cancer and Melanoma, Disappointing Results in HNSCC, and More   FDA Approvals in CRC, Blood Cancer Detection Diagnostic, and Alopecia, and More   FDA Approval of Durvalumab for Advanced Bladder Cancer   FDA Approvals in CRC, Blood Diagnostic, and Alopecia, and More   Dr. Balar on the Approval of Pembrolizumab for Bladder Cancer   Extended Adjuvant Therapy for HER2-Positive Breast Cancer   FDA Approval of Atezolizumab for Advanced Bladder Cancer   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   'Our Cancer Drug Is For Rich Westerners, Not Poor Indians'   A Highly Effective Cancer Treatment Has Just Been Approved by the FDA   What's next in fighting cancer with polio virus?   Novartis Metastatic Breast Cancer Treatment   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   FDA Approval in CLL, Recommendation in NSCLC, Missed Endpoint in GBM Study, and More   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   Breakthrough gene therapy approved in fight against cancer   FDA Approval: Frontline Ceritinib for ALK+ NSCLC   New gene therapy could win fight against cancer   Combined Immunotherapy and Chemotherapy for NSCLC   New treatment for dangerous form of cancer to be fast-tracked by FDA   Dr. Plimack on the Challenges With Available Immunotherapies for Bladder Cancer   FDA Approves First Gene Therapy To Successfully Treat Cancer | NBC Nightly News   Promising Parkinson's research in San Diego   FDA Approval in Lung Cancer, Promising Findings in Hodgkin Lymphoma, and More   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Frontline Atezolizumab for Advanced Bladder Cancer   Recent FDA Approval of Ribociclib as Upfront Therapy   FDA Working To Eliminate Orphan Designation Backlog   Cellectis CEO: Creating A Cancer Fighting Machine | Mad Money | CNBC   FDA Approval Sought in Multiple Myeloma, 2017 AACR Annual Meeting Highlights, and More   Key Considerations for Treating Recurrent Ovarian Cancer   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   FDA Approves Breakthrough Cancer Treatment   FDA Approval of Brigatinib for ALK+ NSCLC   Bold cancer treatment granted breakthrough status   FDA pulls Keytruda from two clinical trials after deaths   Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma   Personalised medicine could lead to a breakthrough in cancer in 2017   Dr. Steinberg on the FDA Approval of Atezolizumab in Bladder Cancer   FDA: Ecstasy 'Breakthrough Therapy' for PTSD   Pembrolizumab in Newly Diagnosed Squamous NSCLC

Popular Today

  TRUMP IMPEACHMENT TRIAL: Will the Republican defense team strategy withstand Democrats?   Mila Kunis And Ashton Kutcher Made A Rare Appearance Together On A Date Night At Sundance   武汉封城第四天 隔离民众花式打发时间   Local elementary school uses Chiefs as model for better learning   Former Marshall County Clerk imprisoned for misuse of public funds   Bulls React To Death Of Lakes Legend Kobe Bryant   Local basketball players react to loss of Kobe, Gianna Bryant   PPD identifies man who allegedly stabbed girlfriend in Walgreens   BREAKING NEWS | MEC Lebogang Maile reverses suspension of DA councillors   President Ilham Aliyev`s interview to Rossiya 24 TV channel   Libya conflict: At least 11 gov't soldiers killed near Misrata   EC Takes Cognisance Of Union Min Anurag Thakur's Provocative Speech   보수단체 "중국 정부, 신종 코로나 늑장 대응" 규탄 / YTN   భూకంపం రాదు భయపడకండి... | ABN Telugu   M-Kopa partners with Samsung and Safaricom   Govt contacting with Chinese authorities to bring back Indians from China: Harsh Vardhan   వేములవాడ ఆలయంలో భక్తుల మధ్య గొడవ | Clashes Between Devotees in Vemulawada | ABN Telugu   En un minuto: El helicóptero en el que iba Kobe Bryant trataba de elevarse sobre una capa de nubes c   We're proud that India has young population but thinking should be young too: PM Modi   Mumbai | माघी गणेश जयंतीचा उत्साह | Marathi News   Michigan Vs Nebraska Pick 01/28/20 Free College Basketball Picks, Predictions, Betting Odds & Tips   తెలుగు రాష్ట్రాల్లో బలపడేందుకు అమిత్ షా పన్నాగం నెరవేరుతుందా..? | Open Secret   Bring It!: It's DOLL VS. DOLL in Scholarship SOLO BATTLE (Season 3 Flashback) | Lifetime   Yahaya Bello Sworn In As Governor   David Moyes FULL Pre-Match Press Conference - West Ham v Liverpool - Premier League   "You want my 9yo in PRISON?" Ted Cruz GOES AFTER reporter after OUTRAGEOUS question   Conferencia de prensa Trump y Netanyahu.   Xbox Series X To Push Higher Frame Rate Over Resolution - Phil Spencer Says   Profile: Judd Semingson, CEO of Community Clinic   More investigations into cause of helicopter crash the took life of Kobe Bryant, 8 others   Rep. Stefanik stumps "I don't understand" Reporter   'Project Runway' Assistant Testifies at Harvey Weinstein Trial   18-year-old facing second-degree murder charges   WINE TRAVEL: Wine Enthusiast's Susan Kostrzewa On Best Wine Travel Destinations In 2020   UB: Bulkang Taal, nananatili sa alert level 3   Kobe Bryant se despidió de la NBA reconociendo la importancia de los latinos | Noticias Telemundo   Portion of Cameron Road closed in northeast Austin due to water main break   दिल्ली-NCR में बदला मौसम का मिजाज, हुई झमाझम बारिश | IndiaTV News   "She Has Not Done Enough To Take On CAA" Says Left Attacks Mamata Govt On Resolution   January 27 marks 75 years since the liberation of Auschwitz   28th Jan '20 | Ghantaravam 9 AM | ETV Telangana | ETV Win   WHO official in China on Wuhan lockdown   Coronavirus death toll rises to 106 with China taking strict measures   Indian Navy Aircraft spotted Chinese vessel in Indian Ocean   Actor Allu Arjun and Director Trivikram Shares Memories | of Ala Vaikunthapurramuloo Movie   TRS Party Owns Nereducharla Municipal Chairman Seat | Sakshi TV   Mayor De Blasio Likens Coronavirus To SARS   Coronovirus Disinformation: Battle against fake news amid outbreak   Local Government | Maile gives reasons for rescinding suspensions of DA Councillors   Adoptive father testified accused rapist was abused as child   View All Today's Popular Videos